{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:34:31Z","timestamp":1778261671319,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,10]],"date-time":"2008-06-10T00:00:00Z","timestamp":1213056000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1038\/sj.bjc.6604408","type":"journal-article","created":{"date-parts":[[2008,6,10]],"date-time":"2008-06-10T07:58:35Z","timestamp":1213084715000},"page":"14-22","source":"Crossref","is-referenced-by-count":64,"title":["Effect of treatment with epoetin-\u03b2 on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies including 2301 patients"],"prefix":"10.1038","volume":"99","author":[{"given":"M","family":"Aapro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Scherhag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H U","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,10]]},"reference":[{"key":"BF6604408_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.bjc.6603481","volume":"95","author":"M Aapro","year":"2006","unstructured":"Aapro M, Coiffier B, Dunst J, \u00d6sterborg A, Burger HU (2006) Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis. Br J Cancer 95: 1467\u20131473","journal-title":"Br J Cancer"},{"key":"BF6604408_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1200\/JCO.2007.11.5378","volume":"26","author":"M Aapro","year":"2008","unstructured":"Aapro M, Leonard RC, Barnadas A, Marangolo M, Untch M, Malamos N, Mayordomo J, Reichert D, Pedrini JL, Ukarma L, Scherhag A, Burger H-U (2008) Effect of once weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and\/or taxane-based chemotherapy\u2013results of the BRAVE study. J Clin Oncol 26: 592\u2013598","journal-title":"J Clin Oncol"},{"issue":"Suppl 6","key":"BF6604408_CR3","first-page":"A530","volume":"37","author":"D Antonadou","year":"2001","unstructured":"Antonadou D, Cardamakis E, Puglisi M (2001) Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies: final results of a randomized phase III study. Eur J Cancer 37 (Suppl 6): A530","journal-title":"Eur J Cancer"},{"key":"BF6604408_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jnci\/dji087","volume":"97","author":"J Bohlius","year":"2005","unstructured":"Bohlius J, Langensiepen S, Schwarzer G, Seidenfeld J, Piper M, Bennett C, Engert A (2005) Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. J Natl Cancer Inst 97: 489\u2013498","journal-title":"J Natl Cancer Inst"},{"key":"BF6604408_CR5","volume-title":"Cochrane Database of Systematic Reviews","author":"J Bohlius","year":"2006","unstructured":"Bohlius J, Wilson J, Seidenfeld S, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennet CL, Langensiepen S, Hyde C, Engert A (2006) Erythropoietin or darbepoetin for patients with cancer. Cochrane Database of Systematic Reviews, Issue 3. Art No.: CD003407, DOI: 10.1002\/14651858.CD003407.pub4"},{"key":"BF6604408_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejca.2006.10.014","volume":"43","author":"C Bokemeyer","year":"2007","unstructured":"Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, \u00d6sterborg A, Repetto L, Soubeyran P, European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly (2007) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 43: 258\u2013270","journal-title":"Eur J Cancer"},{"issue":"Suppl. 3","key":"BF6604408_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1365-2362.2005.01527.x","volume":"35","author":"C Bokemeyer","year":"2005","unstructured":"Bokemeyer C, Oechsle K, Hartmann J-T (2005) Anaemia in cancer patients: pathophysiology, incidence and treatment. Eur J Clin Invest 35 (Suppl. 3): 26\u201331","journal-title":"Eur J Clin Invest"},{"key":"BF6604408_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/sj.bjc.6600801","volume":"88","author":"M Boogaerts","year":"2003","unstructured":"Boogaerts M, Coiffier B, Kainz C, Epoetin Beta QOL Working Group (2003) Impact of epoetin beta on quality of life in patients with malignant disease. Br J Cancer 88: 988\u2013995","journal-title":"Br J Cancer"},{"key":"BF6604408_CR9","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","volume":"91","author":"JJ Caro","year":"2001","unstructured":"Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systematic, quantitative review. Cancer 91: 2214\u20132221","journal-title":"Cancer"},{"key":"BF6604408_CR10","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood.V86.12.4446.bloodjournal86124446","volume":"86","author":"M Cazzola","year":"1995","unstructured":"Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegier L, Essers U, Greil R, Grossi A, Jager G, Le Mevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B (1995) Recombinant human erythropoietin in the anaemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response. Blood 86: 4446\u20134453","journal-title":"Blood"},{"key":"BF6604408_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/cncr.10763","volume":"95","author":"J Crawford","year":"2002","unstructured":"Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy JA (2002) Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 95: 888\u2013895","journal-title":"Cancer"},{"key":"BF6604408_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00066-004-9191-2","volume":"180","author":"J Dunst","year":"2004","unstructured":"Dunst J (2004) Erythropoietin and radiotherapy: a dangerous combination ? Strahlenther Onkol 180: 133\u2013135","journal-title":"Strahlenther Onkol"},{"key":"BF6604408_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0360-3016(01)01488-2","volume":"50","author":"CM Glaser","year":"2001","unstructured":"Glaser CM, Millesi W, Kornek GV, Long S, Schull B, Watzinger F, Selzer E, Lavey RS (2001) Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50: 705\u2013715","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6604408_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","volume":"362","author":"M Henke","year":"2003","unstructured":"Henke M, Laszig R, Rube C, Schafer U, Hasse KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled, trial. Lancet 362: 1255\u20131260","journal-title":"Lancet"},{"key":"BF6604408_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2168.1998.00564.x","volume":"85","author":"C Kettelhack","year":"1998","unstructured":"Kettelhack C, Hones C, Messinger D, Schlag PM (1998) Randomized multicenter trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 85: 63\u201367","journal-title":"Br J Surg"},{"key":"BF6604408_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0140-6736(03)15185-9","volume":"363","author":"B Leyland-Jones","year":"2004","unstructured":"Leyland-Jones B, Mahmud S (2004) Erythropoietin to treat anaemia in patients with head and neck cancer [letter]. Lancet 363: 80","journal-title":"Lancet"},{"key":"BF6604408_CR17","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","volume":"23","author":"B Leyland-Jones","year":"2005","unstructured":"Leyland-Jones B, Semiglazov V, Pawlicki M, Pienkowski T, Tjulandi S, Makhson A, Roth A, Dodwell D, Basalga J, Biakhov M, Valuckas K, Voznui E, Lui X, Vercammen E (2005) Maintaining normal hemoglobin levels with epoetin alfa in mainly non-anaemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 23: 5960\u20135972","journal-title":"J Clin Oncol"},{"key":"BF6604408_CR18","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","volume":"19","author":"TJ Littlewood","year":"2001","unstructured":"Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapaport B, Epoetin Alfa Study Group (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled clinical trial. J Clin Oncol 19: 2865\u20132874","journal-title":"J Clin Oncol"},{"key":"BF6604408_CR19","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","volume":"40","author":"H Ludwig","year":"2004","unstructured":"Ludwig H, van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D (2004) The European Cancer Anemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients. Eur J Cancer 40: 2293\u20132306","journal-title":"Eur J Cancer"},{"key":"BF6604408_CR20","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1073\/pnas.081275298","volume":"98","author":"M Mittelman","year":"2001","unstructured":"Mittelman M, Neumann D, Peled A, Kanter P, Haren-Ghera N (2001) Erythropoietin induces tumour progression and antitumour immune responses in murine myeloma models. Proc Natl Acad Sci USA 98: 5181\u20135186","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6604408_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1023\/A:1008296622469","volume":"9","author":"C Oberhoff","year":"1998","unstructured":"Oberhoff C, Neri B, Amadori D, Petry KU, Gamucci T, Rebmann U, Nowrousian MR, Voigtmann R, Monfardini S, Armand JP, Herrman R, Netter-Pinon J, Tubiana-Mathiew N, Zwierzina H (1998) Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study. Ann Oncol 9: 255\u2013260","journal-title":"Ann Oncol"},{"key":"BF6604408_CR22","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood.V87.7.2675.bloodjournal8772675","volume":"87","author":"A \u00d6sterborg","year":"1996","unstructured":"\u00d6sterborg A, Boogaerts MA, Cimino R, Essers U, Holowiecki J, Juliusson G, Jager G, Najmen A, Peest D (1996) Recombinant human erythropoietin in transfusion-dependent anaemic patients with multiple myeloma and non-Hodgkin's lymphoma\u2013a randomized multicenter study. Blood 87: 2675\u20132682","journal-title":"Blood"},{"key":"BF6604408_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2141.2005.05440.x","volume":"129","author":"A \u00d6sterborg","year":"2005","unstructured":"\u00d6sterborg A, Brandberg Y, Hedenus M (2005) Impact of epoetin-beta on survival of patients with lymphoproliferative malignancies: a long-term follow up of a large randomized study. Br J Haematol 129: 206\u2013209","journal-title":"Br J Haematol"},{"key":"BF6604408_CR24","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1200\/JCO.2002.08.131","volume":"20","author":"A \u00d6sterborg","year":"2002","unstructured":"\u00d6sterborg A, Brandberg Y, Molostova V, Iosava G, Abdulkdyrov K, Hedenus M, Messinger D, Epoetin Beta Hematology Study Group (2002) Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies. J Clin Oncol 20: 2486\u20132494","journal-title":"J Clin Oncol"},{"issue":"6","key":"BF6604408_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1359-6349(07)70099-X","volume":"5","author":"J Overgaard","year":"2007","unstructured":"Overgaard J, Hoff C, Sand Hansen H, Specht L, Overgaard M, Grau C, Andersen E, Johansen J, Anderson L, Evensen J (2007) Randomized study of the importance of novel erythropoiesis stimulating protein (Aranesp\u00ae) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) \u2013 the Danish Head and Neck Cancer Group DAHANCA 10. Eur J Cancer Supplements, 5 (6): 7","journal-title":"Eur J Cancer"},{"key":"BF6604408_CR26","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0959-8049(98)00021-5","volume":"34","author":"B Rau","year":"1998","unstructured":"Rau B, Schlag PM, Willeke F, Herforth C, Stephen P, Frake W (1998) Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO). Eur J Cancer 34: 992\u2013998","journal-title":"Eur J Cancer"},{"issue":"7","key":"BF6604408_CR27","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1200\/JCO.2007.14.2885","volume":"26","author":"RE Smith Jr","year":"2008","unstructured":"Smith Jr RE, Aapro MS, Ludwig H, Pint\u00e9r T, Smakal M, Ciuleanu TE, Chen L, Lillie T, Glaspy JA (2008) Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. J Clin Oncol 26 (7): 1040\u20131050","journal-title":"J Clin Oncol"},{"issue":"3","key":"BF6604408_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1525-1438.2007.01032.x","volume":"18","author":"HG Strauss","year":"2008","unstructured":"Strauss HG, Haensgen G, Dunst J, Hayward CR, Burger HU, Scherhag A, Koelbl H (2008) Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer. Int J Gynecol Cancer 18 (3): 515\u2013524","journal-title":"Int J Gynecol Cancer"},{"key":"BF6604408_CR29","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0360-3016(03)00012-9","volume":"55","author":"G Stuben","year":"2003","unstructured":"Stuben G, Pottgen C, Knuhmann K, Schmidt K, Stusche M, Thews O, Vaupel P (2003) Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice. Int J radiat Oncol Biol Phy 55: 1358\u20131362","journal-title":"Int J radiat Oncol Biol Phy"},{"key":"BF6604408_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF02821936","volume":"15","author":"WW ten Bokkel Huinink","year":"1998","unstructured":"ten Bokkel Huinink WW, de Swart CA, van Toorn DW, Morack G, Breed WP, Hillen HF, van der Haeven JJ, Reeds NS, Fairlamb DJ, Chan SY, Godfrey KA, Kristenson GB, van Tinteren H, Ehmer B (1998) Controlled, multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy. Med Oncol 15: 174\u2013182","journal-title":"Med Oncol"},{"key":"BF6604408_CR31","first-page":"1358","volume":"61","author":"O Thews","year":"2001","unstructured":"Thews O, Kelleher DK, Vaupel P (2001) Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res 61: 1358\u20131361","journal-title":"Cancer Res"},{"key":"BF6604408_CR32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/jnci\/94.16.1211","volume":"94","author":"J Vansteenkiste","year":"2002","unstructured":"Vansteenkiste J, Pirker R, Massuti B, Barata F, Font A, Fiegl M, Siena S, Gatkey J, Tomita D, Colowick AB, Musil J, Aranesp 980297 Study Group (2002) Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy. J Natl Cancer Inst 94: 1211\u20131220","journal-title":"J Natl Cancer Inst"},{"key":"BF6604408_CR33","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0140-6736(04)15802-9","volume":"363","author":"P Vaupel","year":"2004","unstructured":"Vaupel P, Mayer A (2004) Erythropoietin to treat anaemia in patients with head and neck cancer [letter]. Lancet 363: 992","journal-title":"Lancet"},{"key":"BF6604408_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta11130","volume":"11","author":"J Wilson","year":"2007","unstructured":"Wilson J, Yao GL, Raffery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C (2007) A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess 11: 1\u2013202","journal-title":"Health Technol Assess"},{"issue":"9","key":"BF6604408_CR35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1200\/JCO.2006.07.1514","volume":"25","author":"JR Wright","year":"2007","unstructured":"Wright JR, Ung YC, Julian JA, Pritchard KI, Whelan TJ, Smith C, Szechtman B, Roa W, Mulroy L, Rudinskas L, Gagnon B, Okawara GS, Levine MN (2007) Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 25 (9): 1021\u20131023","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604408","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:33:26Z","timestamp":1684413206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BF6604408"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604408","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,10]]}}}